CVE-2022-26235

7.8 highEPSS 0.2%

High (7.8) in beckmancoulter remisol advance. EPSS 0.2% chance of exploitation in the next 30 days.

A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrite and/or manipulate executables and libraries that run as the elevated SYSTEM user on Windows.

Severity

CVSS 3.1

7.8 high

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

EPSS: 0.2% chance of exploitation in the next 30 days; higher than 9% of CVEs (scores of 2026-10-31)
CWE: CWE-276
Published: 2022-10-06
Modified: 2026-06-17
Record from: the NVD, synced 2026-10-19

Affected

beckmancoulter:remisol_advance

References

https://pastebin.com/amgw9pE7
https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance
https://pastebin.com/amgw9pE7
https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance

Check your stack JSON